Role of Huntingtin in Vesicle Transport
Role of Huntingtin in Vesicle Transport
批准号:
6646477
负责人:
Marian DiFiglia
金额:
$59.36万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-15 至 2006-07-31
关键词:
Huntington's disease autophagy calpain cell death cell line cellular pathology chemical cleavage genetically modified animals glutamine immunocytochemistry immunofluorescence technique immunoprecipitation intracellular transport laboratory mouse molecular pathology mutant neurons protein localization protein protein interaction proteins tissue /cell culture vesicle /vacuole western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A polygutamine expansion in the N-terminus of huntingtin (N-hn) causes Huntington's disease (HD). There is no effective treatment for HD. Although mutant N-Fin fragments are known to accumulate in HD neurons and cause cell dysfunction in vitro, a mechanism (or mechanisms) that explains the selective loss of striatal and cortical projection neurons remains elusive. Wild type and mutant htt associate with membranes in the endocytic and secretory pathway. Our overall hypothesis is that mutant N-htt 's association with neuronal membranes contributes to early cellular dysfunction in the cytoplasm in HD. One of these membrane compartments includes the autophagosome/lysosomal system, which accumulates full-length or large N-htt fragments of mutant htt. Although htt ostensibly lacks transmembrane domains, it associates tightly with membranes. We speculate that candidate domains in the N-terminus involved in protein-protein interactions promote membrane binding. Little is known about the degradative pathways that form N-htt fragments in vivo. Identifying the sites of protease cleavage in the N-terminus of htt is important for understanding how the protein is regulated. Calpain, a calcium dependent protease, which regulates the function of many proteins involved in membrane/cytoskeleton organization, cleaves htt near its N-terminus and produces long-lived N-htt fragments that are enriched in membrane fractions in brain. We speculate that mutant N-htt products of calpain cleavage undergo a different processing from the wt fragments in neurons that leads to cellular dysfunction in HD. HD mice also show abnormal function of striatal NMDA receptors. One way that mutant Fin might cause the dysfunction of NMDA receptors is by disrupting the assembly of NMDA receptor subtypes at the cell surface. The specific aims are: 1: To understand the role of mutant htt induced autophagy in cell dysfunction, 2: To determine whether htt proteolysis by calpain contributes to HD pathogenesis and 3: To determine the effects of mutant htt on protein transport within the secretory pathway. The results of these studies will provide new insights about the mechanisms of cellular dysfunction in HD and suggest novel therapeutic targets that can reduce the potentially harmful effects of mutant N-htt fragments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increase Rab11 Activity as HD Therapy
-
批准号:8690180
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2011
-
负责人:Marian DiFiglia
-
依托单位:
Increase Rab11 Activity as HD Therapy
-
批准号:8237338
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2011
-
负责人:Marian DiFiglia
-
依托单位:
Increase Rab11 Activity as HD Therapy
-
批准号:8501038
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2011
-
负责人:Marian DiFiglia
-
依托单位:
Increase Rab11 Activity as HD Therapy
-
批准号:8338826
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2011
-
负责人:Marian DiFiglia
-
依托单位:
Request for electron microscope
-
批准号:7792771
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2010
-
负责人:Marian DiFiglia
-
依托单位:
HUNTINGTON AND VESICLE TRANSPORT
-
批准号:6393832
-
项目类别:
-
资助金额:$30.98万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
HUNTINGTON AND VESICLE TRANSPORT
-
批准号:2892149
-
项目类别:
-
资助金额:$29.21万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
HUNTINGTON AND VESICLE TRANSPORT
-
批准号:2698856
-
项目类别:
-
资助金额:$31.56万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
Role of Huntingtin in Vesicle Transport
-
批准号:6779055
-
项目类别:
-
资助金额:$61.14万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
HUNTINGTON AND VESICLE TRANSPORT
-
批准号:6188098
-
项目类别:
-
资助金额:$30.08万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
HUNTINGTON AND VESICLE TRANSPORT
-
批准号:6095815
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
Role of Huntingtin in Vesicle Transport
-
批准号:6543615
-
项目类别:
-
资助金额:$52.88万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
Role of Huntingtin in Vesicle Transport
-
批准号:6927160
-
项目类别:
-
资助金额:$62.98万
-
财政年份:1998
-
负责人:Marian DiFiglia
-
依托单位:
CORE--IMAGING
-
批准号:6333962
-
项目类别:
-
资助金额:$8.09万
-
财政年份:1980
-
负责人:Marian DiFiglia
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于FGL2-THBS1-Autophagy信号通路探索复方清痹片治疗
类风湿关节炎的效应及机制研究
-
批准号:2024JJ9459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:黄上
-
依托单位:
SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
-
批准号:32300626
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙梁博
-
依托单位:
FLT3/ITD突变细胞与骨髓微环境通过 autophagy互话促发急性髓系白血病的耐药
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:余国攀
-
依托单位:
Fam60a-Autophagy通路调控肝再生的作用机制研究
-
批准号:82100644
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:水丽燕
-
依托单位:
ERAD和Autophagy通路协同调控proAVP在内质网中质量控制的分子机理与中枢性尿崩症
-
批准号:82070811
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:石国军
-
依托单位:
Tuftsin修饰阿魏酸调控“Autophagy-Ferroptosis”信号通路靶向增强抗PPV作用机制研究
-
批准号:32072906
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:马霞
-
依托单位:
人参皂苷Rg1经AMPK/CARM1/Autophagy信号缓解急性肝损伤中的研究
-
批准号:LY19H030004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:邵初晓
-
依托单位:
AMPK-mTOR-Autophagy信号通路在HER2阳性乳腺癌细胞Lapatinib耐药过程中的作用机制及干预研究
-
批准号:81202091
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈苏宁
-
依托单位:
自噬(Autophagy)及其信号途径在细胞衰老及衰老相关疾病中的作用研究
-
批准号:31040051
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:王小丹
-
依托单位:
三类磷酸肌醇3-激酶复合体及其下游效应蛋白对细胞自噬(Autophagy)的调控
-
批准号:30971441
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:谢志平
-
依托单位: